Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penelope Ward

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 27, 2006
The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysisRichard Robson, Adrian Buttimore, Kelvin Lynn, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirinCharles Oo, Joanne Barrett, Albert Dorr, et al.
The Journal of Antimicrobial Chemotherapy|February 15, 2005
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemicPenelope Ward, Ian Small, James Smith, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2003
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antiviralsNeil M Ferguson, Susan Mallett, Helen Jackson, et al.
European Journal of Clinical Pharmacology|August 12, 2003
Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 yearsCharles Oo, George Hill, Albert Dorr, et al.
Archives of Internal Medicine|July 30, 2003
Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizationsLaurent Kaiser, Cynthia Wat, Tracy Mills, et al.
Journal of Clinical Microbiology|February 5, 2002
Role of picornaviruses in flu-like illnesses of adults enrolled in an oseltamivir treatment study who had no evidence of influenza virus infectionGuy Boivin, Albert D Osterhaus, Annie Gaudreau, et al.
Pediatrics|May 3, 2002
Viral respiratory infection in schoolchildren: effects on middle ear pressureBirgit Winther, Frederick G Hayden, Eurico Arruda, et al.
British Journal of Pharmacology|January 25, 2020
Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in miceAnika Kasprick, Maxi Hofrichter, Bryan Smith, et al.
The Journal of Infectious Diseases|January 28, 2004
Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxisFrederick G Hayden, Robert Belshe, Catalina Villanueva, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 27, 2006
The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysisRichard Robson, Adrian Buttimore, Kelvin Lynn, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirinCharles Oo, Joanne Barrett, Albert Dorr, et al.
The Journal of Antimicrobial Chemotherapy|February 15, 2005
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemicPenelope Ward, Ian Small, James Smith, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2003
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antiviralsNeil M Ferguson, Susan Mallett, Helen Jackson, et al.
European Journal of Clinical Pharmacology|August 12, 2003
Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 yearsCharles Oo, George Hill, Albert Dorr, et al.
Archives of Internal Medicine|July 30, 2003
Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizationsLaurent Kaiser, Cynthia Wat, Tracy Mills, et al.
Journal of Clinical Microbiology|February 5, 2002
Role of picornaviruses in flu-like illnesses of adults enrolled in an oseltamivir treatment study who had no evidence of influenza virus infectionGuy Boivin, Albert D Osterhaus, Annie Gaudreau, et al.
Pediatrics|May 3, 2002
Viral respiratory infection in schoolchildren: effects on middle ear pressureBirgit Winther, Frederick G Hayden, Eurico Arruda, et al.
British Journal of Pharmacology|January 25, 2020
Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in miceAnika Kasprick, Maxi Hofrichter, Bryan Smith, et al.
The Journal of Infectious Diseases|January 28, 2004
Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxisFrederick G Hayden, Robert Belshe, Catalina Villanueva, et al.
Pageof 2